Residual treatment disparities after oncology referral for rectal cancer

Journal of the National Cancer Institute

Volumn 100, Issue 10, 2008, Pages 738-744

  Morris, Arden M ^a,b   Billingsley, Kevin G ^d   Hayanga, Awori J ^a   Matthews, Barbara ^c   Baldwin, Laura Mae ^c   Birkmeyer, John D ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER THERAPY; COMORBIDITY; DECISION MAKING; DOCTOR PATIENT RELATION; EUROPEAN AMERICAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT REFERRAL; PRIORITY JOURNAL; RACE DIFFERENCE; RECTUM CANCER; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER REGISTRY; CAUCASIAN; CLINICAL PRACTICE; CONFIDENCE INTERVAL; ETHNOLOGY; HEALTH CARE DELIVERY; MEDICAL RECORD; MEDICARE; ONCOLOGY; PATHOLOGY; RECTUM TUMOR; STATISTICAL MODEL; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; DECISION MAKING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; LOGISTIC MODELS; MALE; MEDICAL ONCOLOGY; MEDICAL RECORD LINKAGE; MEDICARE; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; RADIATION ONCOLOGY; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REFERRAL AND CONSULTATION; SEER PROGRAM; UNITED STATES;

EID: 44449124634     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn145     Document Type: Article

References (41)

1. Dahlberg M, Pahlman L, Bergstrom R, Glimelius B. Improved survival in patients with rectal cancer: a population-based register study. Br J Surg. 1998;85(4):515-520.
2. Vauthey JN, Marsh RW, Zlotecki RA, et al. Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann Surg. 1999;229(5):745-752;discussion 752-754.
3. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007. Based on November 2006 SEER data submission, posted to the SEER Web site. Available at: http://seer.cancer.gov/csr/1975_2004/. [Last accessed: August 20, 2007].
4. Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005;104(3):629-639.
5. Wudel LJ Jr, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002;137(5):550-554;discussion 554-556.
6. Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54(4):359-366.
7. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106- 2113.
8. Morris AM, Wei Y, Birkmeyer NJ, Birkmeyer JD. Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg. 2006;203(6):787-794.
9. Katz JN. Patient preferences and health disparities. JAMA. 2001;286(12):1506-1509.
10. Kim C, Kabeto MU, Wallace RB, Langa KM. Quality of preventive clinical services among caregivers in the health and retirement study. J Gen Intern Med. 2004;19(8):875-878.
11. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165(18):2098-2104.
12. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998;21(suppl 3):C11-C14.
13. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294(21):2703-2711.
14. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351(6):575-584.
15. Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in Medicare managed care. JAMA. 2002;287(10):1288-1294.
16. Polednak AP. Segregation, discrimination and mortality in U.S. blacks. Ethn Dis. 1996;6(1-2):99-108.
17. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(suppl 8):IV-3-18.
18. Greene F, Page D, Fleming I eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
19. Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care. 2006;44(8):745-753.
20. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690- 1691.
21. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264(11):1444-1450.
22. Baxter NN, Rothenberger DA, Morris AM, Bullard KM. Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States. Dis Colon Rectum. 2005;48(1):9-15.
23. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324(11):709-715.
24. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92(4):896-902.
25. Jessup JM, Loda M, Bleday R. Clinical and molecular prognostic factors in sphincter-preserving surgery for rectal cancer. Semin Radiat Oncol. 1998;8(1):54-69.
26. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21(7):1293-1300.
27. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93(11):850-857.
28. Mahoney T, Kuo YH, Topilow A, Davis JM. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg. 2000;135(2):182-185.
29. Oliveria SA, Yood MU, Campbell UB, Yood SM, Stang P. Treatment and referral patterns for colorectal cancer. Med Care. 2004;42(9):901-906.
30. Carlos RC, Fendrick AM, Patterson SK, Bernstein SJ. Associations in breast and colon cancer screening behavior in women. Acad Radiol. 2005;12(4):451-458.
31. Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ. Behavioral associations between prostate and colon cancer screening. J Am Coll Surg. 2005;200(2):216-223.
32. Freeman HP. Patient navigation: a community based strategy to reduce cancer disparities. J Urban Health. 2006;83(2):139-141.
33. Dignam JJ, Colangelo L, Tian W, et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst. 1999;91(22):1933-1940.
34. Dignam JJ, Ye Y, Colangelo L, et al. Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials. J Clin Oncol. 2003;21(3):413-420.
35. McCollum AD, Catalano PJ, Haller DG, et al. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002;94(15):1160-1167.
36. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282(6):583-589.
37. Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med. 2003;139(11):907-915.
38. Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97(16):1211-1220.
39. Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst. 2006;98(9):610-619.
40. Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005;294(22):2879-2888.
41. Cohen RA, Martinez ME. Health insurance coverage: early release of estimates from the National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics; 2007.